insights_auto
Outlook: 27.3% bullish·18.2% bearish
Go to analysischevron_right
NKTR:NASDAQ
Nektar Therapeutics
$37.27
arrow_upward
+0.05%(+0.020) 1D
$37.27
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 13, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NKTR...
Open
$36.80
High
$38.70
Low
$36.28
Mkt. cap
1.27B
Avg. vol.
969.08K
Volume
695.17K
52-wk high
$109.00
52-wk low
$33.40
EPS
-$6.69
Beta
1.44
Shares outstanding
34.14M
No. of employees
63
Open
$36.80
High
$38.70
Low
$36.28
Mkt. cap
1.27B
Avg. vol.
969.08K
Volume
695.17K
52-wk high
$109.00
52-wk low
$33.40
EPS
-$6.69
Beta
1.44
Shares outstanding
34.14M
No. of employees
63
News stories
From web sources and news partners
GuruFocus
·
1 hour ago
NKTR SWOT Analysis: Financial Challenges and Pipeline Potential Revealed in 10-Q Filing
Zacks
·
15 hours ago
NKTR Q3 Earnings Beat Estimates, 2026 Revenue View Cut, Stock Down
Zacks Investment Research
·
16 hours ago
NKTR Q3 Earnings Beat Estimates, 2026 Revenue View Cut, Stock Down
Investing.com
·
19 hours ago
Nektar Therapeutics reports $952.9 million in cash and investments as of Q3 By Investing.com
About Nektar Therapeutics
CEO-
Employees63
Founded1990
HeadquartersSan Francisco, California, United States
SectorHealth Care
IndustryBiotechnology
Websitenektar.com